🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Amazing, Demis Hassabis ! "Impossible" is often a good place to start! Congratulations, my friend! theguardian.com/science/2024/o…

We had quite a show in Cambridge a couple of nights ago! Pictures from my back garden!

Our partner Centessa Pharmaceuticals has initiated a Phase 2 trial of ORX750, a novel orexin receptor 2 (OX2R) agonist. The achievement of this milestone results in a payment of US$3.5 million to Nxera. Read more here: ssl4.eir-parts.net/doc/4565/tdnet…

Our CSO Miles Congreve is speaking on a panel ‘How is AI transforming biotech’ at SV Health Investors Forum 2024. Register here to join the webinar: bit.ly/48LE6Zn at 2.00pm in London, Monday 18th November.

How can AI revolutionize the scientific method to bring in a new age of discovery? Eric Topol chaired a fascinating discussion with our VP Science, @Pushmeet and leading biomedical researchers Alison Noble (Vice President, Royal Society) and Fiona Marshall (President of

Happy to share my TED talk recorded live at TEDAI in San Francisco last month, giving an insight into a new paradigm I see emerging: creating AI analogues of our real messy world, to accelerate new scientific breakthroughs. Watch it here: bit.ly/3Z6YyiU Some of the

Watch the moment our CEO Demis Hassabis receives his Nobel Prize diploma and medal alongside fellow chemistry laureates David Baker and John Jumper at the esteemed Nobel Prize award ceremony. #NobelPrize

endpts.com/isomorphic-lab… most in-depth look Isomorphic Labs to date. Thank you for writing this comprehensive and insightful work Andrew Dunn

Happy holidays!

We are pleased to announce our participation in the UK Biobank Pharma Proteomics Project; bringing together a consortium of 14 biopharma companies supporting the UK Biobank in the world’s most comprehensive protein study. This new study aims to increase a unique proteomics

Just heading off to JPM, San Francisco. Looking forward to the week ahead! Doing a dry January. Apart from Champagne obviously.

Back from a great week at JPM exploring future opportunities to leverage our AI-first drug design platform. Looking forward to 2025!

View from my hotel window. Oh.

The largest medical #AI randomized controlled trial yet performed, enrolling >100,000 women undergoing mammography screening, was published today The Lancet Digital Health The use of A.I. led to 29% higher detection of cancer, no increase of false positives, and reduced workload compared

Today is #WorldCancerDay. Behind every diagnosis is a person, family, and friends who feel the devastating effects of cancer. Our work has never been more vital. With pioneering cancer research and groundbreaking discoveries, we can continue bringing hope to future generations.

We are excited to announce the expansion of our collaboration with Novartis, doubling the number of research programs just over a year after initiating our partnership. This expansion is testament to the great progress we’ve made together and further unlocks the potential to

Our expanded collaboration with Novartis is a testament to the progress and potential of our work in reimagining drug discovery. Read more from Demis Hassabis in the full announcement here: isomorphiclabs.com/articles/isomo… #AI #drugdiscovery #machinelearning

Thrilled to announce Isomorphic Labs has raised $600M to turbocharge our mission to one day solve all disease with the help of AI. I've long felt that improving human health is the most important thing we can do with AI & today marks a big step towards a new era of drug

“The future of biology won’t be siloed—it will be collaborative, interdisciplinary, and deeply creative. Demis is helping us get there faster.” We’re thrilled to see our CEO, Demis Hassabis, recognised as one of TIME’s 100 Most Influential People in the world. In this feature,

The ambition at Isomorphic Labs is immense – they’re rethinking drug discovery from the ground up, using AI. 💊 Join Head of Medicinal Drug Design rebecca paul & Chief AI Officer Max Jaderberg as they share the possibilities of AI in tackling disease with host @fryrsquared.